About FGFR3
The FGFR3 gene (Fibroblast Growth Factor Receptor 3) on chromosome 4p16 Activating mutations in FGFR3 cause thanatophoric dysplasia and achondroplasia, and recurrent S249C mutations occur in bladder cancer. Key targets include Exons 7–18 (kinase domain, IgIII domain) for comprehensive mutation screening.
Mutations: G380R, R248C, S249C, Y373C, K650E | GC content: 55% | Target exons: Exons 7–18 (kinase domain, IgIII domain)
FGFR3 Primer Design Challenges
- S249C hotspot: The cysteine substitution in exon 7 causes constitutive dimerization and requires specific genotyping primers
- Moderate GC (55%): Balanced GC with localized high-GC pockets in exon 10 requiring optimized touchdown PCR protocols
- Dual disease spectrum: Germline skeletal dysplasia vs somatic cancer mutations require different detection thresholds (germline heterozygous vs somatic low-VAF)
Recommended Primer Design Parameters for FGFR3
| Parameter | Standard Exons | Optimized Regions |
|---|---|---|
| Primer length | 20–22 nt | 22–25 nt |
| GC content | 45–55% | 50–60% |
| Tm | 58–62°C | 60–65°C |
| Amplicon size | 150–300 bp | 180–350 bp |
| Annealing temp | 58–60°C | 60–64°C (touchdown) |
| PCR additive | Standard | Optional 3–5% DMSO for problematic regions |
Recommended Primer Sequences for FGFR3
| Target Region | Forward Primer (5′→3′) | Reverse Primer (5′→3′) | Amplicon |
|---|---|---|---|
| Exon 7 (S249C) | 5′-CAGTGGGATCGGTGCACTAT-3′ | 5′-ACACAGCCTGGTCAAACACA-3′ | 208 bp |
| Exon 10 (G380R) | 5′-TCCAGGCACCCAGAGGATAG-3′ | 5′-GCACACCACCTCCCTTTAGA-3′ | 192 bp |
Key SNPs to Avoid in Primer Binding Sites
When designing FGFR3 primers, avoid these clinically significant variants:
- rs121913450 (S249C) — Exon 7 bladder cancer hotspot
- rs28931615 (G380R) — Exon 10 achondroplasia mutation
- rs121913455 (K650E) — Exon 15 thanatophoric dysplasia
Clinical Validation Required
All FGFR3 primers designed with VigyanLLM are for research use only. Clinical diagnostic applications require additional wet-lab validation, Sanger sequencing confirmation, and regulatory approval before patient use.
Design FGFR3 Primers Now
Pre-configured with FGFR3-specific parameters. Use our primer design, Tm calculator, and GC content tools for optimal results.